EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Estrogen-related receptor α in breast cancer: From molecular insights to targeted therapy

Jagannath Pradhan, Archana Priyadarshini Samal, Uzma Khatoon, Monica Prusty, Selvakumar Elangovan

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2025.189525 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Jagannath Pradhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer outcomes continue to be undermined by metastasis, relapse, and therapeutic resistance. While endocrine and targeted therapies have improved clinical outcomes, aggressive subtypes such as HER2-positive and triple-negative breast cancers remain challenging, exhibiting poor prognosis and frequent relapse. The constitutively active orphan nuclear receptor, estrogen-related receptor α (ERRα), has emerged as a key regulator of tumor energy metabolism and a crucial driver of breast cancer progression. The ERRα overexpression, frequently observed in aggressive subtypes, is strongly correlated with epithelial-mesenchymal transition, angiogenesis, invasion, metastasis, and therapy resistance. Preclinical studies demonstrate that pharmacological inhibition or gene silencing of ERRα suppresses oncogenic signaling and enhances therapeutic sensitivity. This review explores the multifaceted roles of ERRα in breast cancer and highlights its translational potential as a molecular target for treating aggressive breast cancer subtypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenHumansFemaleMolecular Targeted TherapyERRalpha Estrogen-Related ReceptorAnimalsSignal TransductionEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Breast cancerEnergy metabolismEstrogen-related receptor αInvasionMetastasisTherapy resistance

Substanzen

Receptors, EstrogenERRalpha Estrogen-Related Receptor

Autor:innen und Institutionen

  • School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India.
  • School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India. Electronic address: selvakumar@kiitbiotech.ac.in.

Förderung

  • Indian Council of Medical Research
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Pradhan, J., Samal, A. P., Khatoon, U., Prusty, M., & Elangovan, S. (2026). Estrogen-related receptor α in breast cancer: From molecular insights to targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2025.189525

Vancouver

Pradhan J, Samal AP, Khatoon U, Prusty M, Elangovan S. Estrogen-related receptor α in breast cancer: From molecular insights to targeted therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2025.189525

BibTeX
@article{Pradhan2026,
  author = {Pradhan, Jagannath and Samal, Archana Priyadarshini and Khatoon, Uzma and Prusty, Monica and Elangovan, Selvakumar},
  title = {Estrogen-related receptor α in breast cancer: From molecular insights to targeted therapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2025.189525}
}
Kostenlos starten →